Terumo Announces Change of Directors and Executive Officers
TOKYO, JAPAN – February 4, 2021 – Terumo Corporation (TSE: 4543) today announced that it has resolved a change of its Directors and Executive Officers as follows.
1. Change of Director (As of April 1, 2021)
| Name | New Title | Current Title |
| Kyo Nishikawa | Director and Managing Executive Officer Chief Human Resources Officer (CHRO) |
Director and Senior Executive Officer Chief Human Resources Officer (CHRO) |
2. Change of Director (As of June 22, 2021)
| Name | New Title | Current Title |
| Takanori Shibazaki | Director (Audit and Supervisory Committee Member) |
Senior Executive Officer Audit and Supervisory Committee Office |
*Subject to the approval of the Annual General Meeting of Shareholders to be held on June 22, 2021.
*He will arrive at Audit and Supervisory Committee Office from the current position (Regional Representative, China) as of June 1, 2021.
3. Change of Executive Officers (As of April 1, 2021)
| Name | New Title | Current Title |
| Fumihisa Hirose | Senior Executive Officer General Manager, Strategic Planning Dept. Chief Technology Officer (CTO) |
Executive Officer General Manager, Strategic Planning Dept. |
| Masayuki Maruta | Executive Officer President and CEO, Terumo (China) Holdings Co., Ltd. | Chairman, Terumo Medical (Shanghai) Co., Ltd. |
| Hiroshi Yagi | Executive Officer Factory Manager, Ashitaka Factory, Interventional Systems Division, Cardiac and Vascular Company |
Factory Manager, Ashitaka Factory, Interventional Systems Division, Cardiac and Vascular Company |
| Jin Nishizaki | Executive Officer Branch Manager, Tokyo Branch, General Hospital Company |
Branch Manager, Tokyo Branch, General Hospital Company |
4. Change of Executive Officer (As of June 1, 2021)
| Name | New Title | Current Title |
| Masayuki Maruta | Executive Officer Regional Representative, China President and CEO, Terumo (China) Holdings Co., Ltd. |
Executive Officer President and CEO, Terumo (China) Holdings Co., Ltd. |
About Terumo
Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technologies, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.